Medicine: The Inhibitors

The legion of the emotionally depressed had high hopes when iproniazid was found 18 months ago to be an effective treatment in many cases. But the hopes were dashed when it was reported that the drug caused too many dangerous side effects, notably liver damage (TIME, April 21). Since then, instead of being prescribed indiscriminately for office patients, iproniazid is being used so carefully that it appears to be no more dangerous than many another potent drug. It is used not only in psychiatry, but also for cancer patients when they know the end...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!